Pharmaceutical Chemistry Journal

, Volume 27, Issue 10, pp 683–688 | Cite as

1-[4-(2-Hydroxy-3-tert-butylaminopropoxy) indol-3-yl(5-acetamido-1-{s}-carboxypentyl)-DL-alanyl]-L-proline dihydrochloride: A new inhibitor of angiotensin-converting enzymes withβ-adrenoblocking properties

  • M. D. Mashkovskii
  • L. Kh. Vinograd
  • S. D. Yuzhakov
  • O. V. Dolgun
  • N. A. Krit
  • M. P. Filatova
  • E. A. Dukhanina
  • S. F. Dugin
  • Yu. N. Tribunskaya
Molecular-Biological Problems in the Creation of Therapeutic Substances and Studies of Their Mechanisms of Action
Received:

Keywords

Organic Chemistry Dihydrochloride Carboxypentyl 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. G. Glushkov, M. D. Mashkovskii, G. K. Skryabin, et al., Khim.-farm. Zh., No. 6, 18–21 (1992).Google Scholar
  2. 2.
    R. G. Glushkov, M. D. Mashkovskii, N. N. Suvorov, et al., ibid., No. 8, 8–12 (1993).Google Scholar
  3. 3.
    N. A. Krit, I. N. Gracheva, M. D. Filatova, and Z. Raissmaim, ibid., No. 7, 44–47 (1991).Google Scholar
  4. 4.
    E. Gross and I. Mayenhofer (eds.), Peptides [Russian translation], Moscow (1983), p. 104.Google Scholar
  5. 5.
    I. Yu. Sakharov, E. A. Dukhanina, and S. M. Danilov, Biokhimiya,51, 946–951 (1986).Google Scholar
  6. 6.
    S. D. Yuzhakov and M. D. Mashkovskii, Khim.-farm. Zh., No. 8, 918–928 (1986).Google Scholar
  7. 7.
    S. D. Yuzhakov, R. G. Glushkov, and M. D. Mashkovskii, ibid., No. 3, 21–31 (1991).Google Scholar
  8. 8.
    G. Allan, D. Cambridge, G. W. Hardy, et al., J. Hypertens.,4, Suppl. 6, 5131–5133 (1986).Google Scholar
  9. 9.
    G. Allan, G. M. Hardy, D. Bull, et al., EP 0234946 (1987).Google Scholar
  10. 10.
    E. Bouley, J. M. Teulon, M. Cares, et al., J. Med. Chem.,29, 100–103 (1986).Google Scholar
  11. 11.
    H. Flohr, H. W. Dahners, and W. Breul, Arzneimittel. Forsch.,25, 985–987 (1975).Google Scholar
  12. 12.
    G. W. Hardy, D. Bull, H. T. Jones, et al., Tetrahedron Lett.,29, No. 7, 799–802 (1988).Google Scholar
  13. 13.
    B. G. Main and H. Tucker, Progr. Med. Chem.,22, 122–163 (1985).Google Scholar
  14. 14.
    A. A. Patchett, E. Harris, M. J. Wyvratt, E. Tristam, EP 0012401 (1984).Google Scholar
  15. 15.
    J. Piqilloud, A. Reinharz, and M. Roth, Biochim. Biophys. Acta.,206, No. 1, 136–142 (1970).Google Scholar
  16. 16.
    A. M. Rudolph and M. A. Heymann, Circulat. Res.,21, 163–184 (1967).Google Scholar
  17. 17.
    R. A. Slater, W. Howson, G. T. G. Swayne, et al., J. Med. Chem.,31, 345–351 (1988).Google Scholar
  18. 18.
    Y. Uchida, M. Nakamura, S. Shimizu, et al., Arch. Int. Pharmacodyn.,262, No. 1, 132–149 (1983).Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • M. D. Mashkovskii
    • 1
    • 2
    • 3
    • 4
  • L. Kh. Vinograd
    • 1
    • 2
    • 3
    • 4
  • S. D. Yuzhakov
    • 1
    • 2
    • 3
    • 4
  • O. V. Dolgun
    • 1
    • 2
    • 3
    • 4
  • N. A. Krit
    • 1
    • 2
    • 3
    • 4
  • M. P. Filatova
    • 1
    • 2
    • 3
    • 4
  • E. A. Dukhanina
    • 1
    • 2
    • 3
    • 4
  • S. F. Dugin
    • 1
    • 2
    • 3
    • 4
  • Yu. N. Tribunskaya
    • 1
    • 2
    • 3
    • 4
  1. 1.Central Laboratory for Drug TrialSergo Ordzhonikidze All-Union Scientific Research Institute of the Chemical and Pharmaceutical IndustryUSSR
  2. 2.IBMKh, Russian Academy of Medical SciencesUSSR
  3. 3.Institute of the Biochemistry and Physiology of MicroorganismsRussian Academy of SciencesUSSR
  4. 4.Institute of Experimental Cardiology, All-Union Cardiologie Science CenterRussian Academy of Medical SciencesMoscow

Personalised recommendations